All In MedTech

Device Trial Radar · NCT05057117

Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis

Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis: a Randomized Intra-individual Trial

Last checked: Nov 19, 2026Latest source record: May 26, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Sep 27, 2021

Primary completion

Oct 17, 2022

Study completion Apr 24, 2023

Sponsor

Lead sponsor
Merete HaedersdalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 27, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial aims is to assess and compare treatment effect of microwave thermolysis and botulinum toxin A for axillary hyperhidrosis with focus on longevity. The investigators also aim to assess patient satisfaction and adverse reactions in relation to treatment.

Conditions

  • Hyperhidrosis Primary Focal Axilla

Interventions

  • Microwave thermolysisDevice

    Baseline treatment with microwave thermolysis in one axilla and botulinum toxin A in the contralateral axilla, as allocated by randomization

  • Botulinum toxin ADrug

    Baseline treatment with microwave thermolysis in one axilla and botulinum toxin A in the contralateral axilla, as allocated by randomization

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subjective change in axillary sweatTime frame: Baseline - 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Dermatology, Bispebjerg Hospital

    Copenhagen, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.